BioSpace News Archive

CARB-X is awarding ContraFect Corporation (Nasdaq:CFRX) of Yonkers, New York, USA, up to $1.75 million in non-dilutive funding with the possibility of $5.19 million more if certain project milestones are met, to develop novel antibiotics to treat serious life-threatening infections caused by Gram-negative ESKAPE pathogens.

Biogen (Nasdaq: BIIB) today announced that it has entered into an agreement to acquire Nightstar Therapeutics (NST; Nasdaq: NITE), a clinical-stage gene therapy company based in London, United Kingdom, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders

AFYS3G launches a unique laser based system to mark labware with 100% reliability: the Lambda8. T

BOC Sciences, a US-based global manufacturer of high-quality chemicals and efficient custom services to support the pharmaceutical industry through all stages of drug discovery, has recently added intermediates synthesis to its API synthesis portfolio.

PTC Therapeutics, Inc. announced that management will present a company update at the following conferences

Odonate Therapeutics, Inc. announced that it has initiated CONTESSA 2, a multinational, multicenter, Phase 2 study of tesetaxel, Odonate’s investigational, orally administered taxane, in patients with locally advanced or metastatic breast cancer who have not previously received a taxane.

Emmes announced that Behrman Capital, a leading private equity firm, has made a significant investment in the company.

Problem Gambling Awareness Month underway across MGM Resorts, highlighting March Madness

International Women’s Day, coming up on Friday, March 8th, is all about challenging stereotypes.

Life Without Ed® and Goodbye Ed, Hello Me® jewelry provides daily armor against eating disorders (a.k.a. Ed), and benefits the National Eating Disorders Association (NEDA).